(This May 28 story has been corrected to say ‘eye drop,’ not ‘liquid medication,’ in paragraph 3 and to remove the picture) (Reuters) -Eye-care drugmaker Alcon said on Wednesday that the U.S. Food and Drug Administration has approved its treatment for dry eye disease (DED). Spun off from Novartis in 2019, Alcon is betting on new product […]
US FDA Approves Alcon’s New Dry-eye Drug Read More »
By Bronwyn Thompson June 27, 2025 Facebook Twitter Flipboard LinkedIn Reddit Trigger happy: High levels of fructose puts your immune system on edge Depositphotos View 1 Images For the first time, scientists have unraveled just how high levels of fructose affect the body, flipping a genetic switch as it’s broken down – one that primes your
Fructose hijacks immune cells to set them on inflammatory “attack mode” Read More »
by Elana Gotkine edited by Gaby Clark, reviewed by Andrew Zinin Empagliflozin has kidney protective effects and reduces heart failure outcomes across baseline kidney function among patients with acute myocardial infarction (MI), according to a study published online June 13 in Nature Cardiovascular Research. Rahul Aggarwal, M.D., from Harvard Medical School in Boston, and colleagues examined the cardiovascular-kidney effects
Empagliflozin has kidney protective effects in acute myocardial infarction Read More »
by Melissa Rohman, Northwestern University edited by Stephanie Baum, reviewed by Andrew Zinin Credit: Unsplash/CC0 Public Domain A drug commonly used to treat type 2 diabetes may reduce excess fluid in the brains of patients with hydrocephalus, which could help treat the disease less invasively than current treatments, according to a Northwestern Medicine study published in the Journal of Clinical Investigation.
Diabetes drug may serve as alternative treatment option for hydrocephalus Read More »
by Katherine Egan Bennett, University of Texas at Arlington edited by Stephanie Baum, reviewed by Andrew Zinin Credit: Langmuir (2025). DOI: 10.1021/acs.langmuir.4c03005 Scientists at The University of Texas at Arlington have identified a new enzyme that can be “turned off” to help the body maintain healthy cholesterol levels—a significant development that could lead to new treatments for diseases that affect
by Simon Fraser University edited by Stephanie Baum, reviewed by Andrew Zinin Rhythmic beta-frequency responses to dopamine replacement therapy (DRT). (A) Brain maps on the left and right indicate the mean and standard deviation, respectively, of region-wise rhythmic beta-frequency neurophysiological responses to DRT. (B) From left to right, brain maps indicate the normative spatial patterns of D1 and
How a drug used to treat Parkinson’s disease might affect the brain Read More »
by Touro University edited by Stephanie Baum, reviewed by Andrew Zinin Structural proteomics reveals isoform differences upon progesterone response element (PRE) binding. Credit: Nature Communications (2025). DOI: 10.1038/s41467-025-59458-y Imagine a drug that halts cancer without side effects or risks. That future may be a bit nearer thanks to recent research led by Raj Kumar, Ph.D., chair of the Department
New study may pave the way for targeted cancer treatments Read More »
Cancer patients in more than 100 countries are at risk of receiving ineffective treatments and potentially fatal side effects, reports a team from the Bureau of Investigative Journalism (TBIJ). Generic drugs are used all around the world, but they’re especially relied upon in places with fewer resources and less access to more expensive treatments.
Generic cancer drugs are failing quality tests Read More »
Download PDF Copy Reviewed Chiba UniversityJun 26 2025 Acute myeloid leukemia (AML) is an aggressive cancer affecting the blood and bone marrow that progresses rapidly, making immediate treatment essential. While chemotherapy and targeted drugs have improved outcomes for some patients, many forms of AML remain resistant to treatment, and relapses are common. A new study sheds
Epigenetic enzyme SETD1B drives aggressive growth in acute myeloid leukemia Read More »
The study led by a team at the EHU has identified hundreds of molecular markers in the oral cavity that can reflect pathological processes in other parts of the body Peer-Reviewed Publication University of the Basque Country FacebookXLinkedInWeChatBlueskyMessageWhatsAppEmail image: Jose Ramon Bilbao Catala and Alba Hernangomez Laderas, main authors of the research. view more Credit: Photo:
Saliva analysis could reveal the risk of developing cancer, heart disease or Parkinson’s Read More »
Vitae, vulputate lorem id egestas neque egestas habitant sit ante nec.
✆ Phone (appointments): 714-639-4013
Email: care@imedmg.com
Address: 615 E Chapman Ave, Suite #300, Orange, CA 92866